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Abstract
Background: The sagittal abdominal diameter (SAD) measured in supine position is an alternative adiposity indicator that
estimates the quantity of dysfunctional adipose tissue in the visceral depot. However, supine SAD’s distribution and its
association with health risk at the population level are unknown. Here we describe standardized measurements of SAD,
provide the first, national estimates of the SAD distribution among US adults, and test associations of SAD and other
adiposity indicators with prevalent dysglycemia.
Methods and Findings: In the 2011–2012 National Health and Nutrition Examination Survey, supine SAD was measured
(‘‘abdominal height’’) between arms of a sliding-beam caliper at the level of the iliac crests. From 4817 non-pregnant adults
(age $20; response rate 88%) we used sample weights to estimate SAD’s population distribution by sex and age groups.
SAD’s population mean was 22.5 cm [95% confidence interval 22.2–22.8]; median was 21.9 cm [21.6–22.4]. The mean and
median values of SAD were greater for men than women. For the subpopulation without diagnosed diabetes, we compared
the abilities of SAD, waist circumference (WC), and body mass index (BMI, kg/m2) to identify prevalent dysglycemia (HbA1c
$5.7%). For age-adjusted, logistic-regression models in which sex-specific quartiles of SAD were considered simultaneously
with quartiles of either WC or BMI, only SAD quartiles 3 (p,0.05 vs quartile 1) and 4 (p,0.001 vs quartile 1) remained
associated with increased dysglycemia. Based on continuous adiposity indicators, analyses of the area under the receiver
operating characteristic curve (AUC) indicated that the dysglycemia model fit for SAD (age-adjusted) was 0.734 for men
(greater than the AUC for WC, p,0.001) and 0.764 for women (greater than the AUC for WC or BMI, p,0.001).
Conclusions: Measured inexpensively by bedside caliper, SAD was associated with dysglycemia independently of WC or
BMI. Standardized SAD measurements may enhance assessment of dysfunctional adiposity.
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Introduction
The body mass index (BMI, weight/height2) is recommended
for clinical and epidemiological assessments of human adiposity
[1,2], but BMI cannot distinguish between lean mass and depots of
adipose tissue (AT). Dependence on the categorical BMI has
sometimes misclassified health risk, leading commentators to call
for the exploration of alternative, low-cost, adiposity metrics [3]. A
candidate alternative indicator is the sagittal abdominal diameter
(SAD) which, when measured externally in the supine position
(‘‘abdominal height’’), estimates the volume of visceral (intra-
abdominal) AT [4,5]. As demonstrated by expensive imaging
technologies, it is primarily the visceral depot of AT (as opposed to
subcutaneous depots) that correlates with cardiometabolic risk [6–
8]. Associations have been found between SAD and chronic-
disease risk factors or outcomes, but these reports depended on
selected research populations and employed varying methods and
positions for measuring SAD [9–16]. Wider use of the SAD would
benefit from a standardized measurement protocol and the
availability of SAD normative reference values.
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This paper describes a simple, inexpensive protocol for SAD
measurement and estimates the distribution of SAD values in the
US adult population examined during 2011–2012. It also
demonstrates how the use of SAD measurements could improve
upon BMI or waist circumference (WC) for the recognition of
impaired glucose regulation (‘‘dysglycemia’’).
Methods
Participants and their clinical measurements
The National Health and Nutrition Examination Survey
(NHANES) is a nationally representative, cross-sectional survey
of the resident civilian, non-institutionalized, US population.
Participants in NHANES underwent home interviews followed by
standardized anthropometric and laboratory assessments in
mobile examination centers. The complex, multistage-probability,
sampling design of NHANES requires sample weights for each
participant so that characteristics of the US population can be
estimated. In the 2011–2012 NHANES, of 5560 interviewed
adults ($20 years old), 5319 were examined, and 4817 had SAD
measurement data. Since pregnant women (n= 57) were not
eligible for SAD measurement, the participation rate for SAD was
88% among non-pregnant interviewees. A general description of
NHANES has been published elsewhere [17].
The SAD was measured using a sliding-beam, abdominal
caliper (Holtain, Ltd, Wales, UK). Supine participants rested on a
lightly padded exam table with their hips in a relaxed, flexed
position as the examiner marked the level of their iliac crests with a
wax pencil. The lower arm of the caliper was then inserted under
the small of the back, and the upper arm was raised above the
belly in alignment with the transverse pencil mark (Figure 1). After
confirming that the caliper shaft was vertical, the examiner asked
the participant to inhale gently, slowly let the air out, and then
pause (‘‘… rest,… relax…’’). The examiner then slid down the
caliper’s upper arm, letting it lightly touch the abdomen but
without compressing it. The SAD value was read directly from the
centimeter scale on the caliper shaft and recorded to the nearest
0.1 cm [18]. Then, after raising the caliper’s upper arm and
repeating breathing instructions, a second SAD measurement was
recorded. If the two SAD values differed by .0.5 cm, third and
fourth measurements were obtained. For this report we defined
each participant’s SAD as the mean of 2 initial measurements or of
up to 4 measurements as specified in the online, analytic notes
from NHANES [19]. Weight, height and a standing-position WC
were measured by established methods [18].
Within our analytic sample we identified adults with diagnosed
diabetes by their affirmative answer to the question ‘‘have you ever
been told by a doctor or other health professional that you have
diabetes or sugar diabetes?’’ For those without diagnosed diabetes
we defined categorical dysglycemia by a glycated hemoglobin
(HbA1c) concentration $5.7% ($39 mmol/mol). This is a
common threshold value that points to an increased risk of
cardiovascular disease [20] as well as to ‘‘prediabetes’’ or
undiagnosed diabetes [21]. Assays of HbA1c in NHANES were
performed on whole-blood hemolysate presented to a high-
performance liquid chromatography column (Fairview Medical
Center Laboratory, University of Minnesota, Minneapolis).
Ethics Statement
The NHANES protocol was approved by the Research Ethics
Review Board of the National Center for Health Statistics;
participants provided informed consent.
Statistical analyses
All analyses accounted for the sampling weights and sample
design using SAS (release 9.3 [SAS Institute Inc., Cary, NC],
SUDAAN (release 11.1) [RTI International, Research Triangle
Park, NC]) or the ‘survey’ package in R [22,23]. We estimated the
distribution of SAD values in 2011–2012 among US adults overall
and by sex and age group (20–34, 35–49, 50–64, and 65+ years).
The means, quartiles, and their corresponding Wald 95%
confidence intervals were calculated using the DESCRIPT
procedure of SUDAAN.
For the subpopulation not diagnosed with diabetes, we then
assessed the utility of SAD compared to other adiposity indicators
(WC or BMI) for identifying prevalent dysglycemia. Our first
approach examined the relation of sex-specific quartiles of SAD,
WC and BMI to this outcome of interest. Predictive margins from
age-adjusted logistic regression models were estimated to provide
Figure 1. Measurement of the sagittal abdominal diameter by use of a sliding-beam caliper in NHANES, 2011–2012.
doi:10.1371/journal.pone.0108707.g001
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prevalence ratios (PRs) relative to the lowest quartile; each model’s
goodness of fit was estimated as R2 (Cox & Snell method). We
examined ordinal quartiles for each adiposity indicator individu-
ally, as well as the independent effect of SAD quartiles in models
that also included either BMI quartiles or WC quartiles.
The three adiposity indicators were highly correlated with each
other, and collinearity might complicate interpretation of the
individual regression coefficients in models that simultaneously
contained SAD and another adiposity indicator. Therefore, we
also calculated receiver operator characteristic curves for each
Figure 2. Panel A: Dysglycemia prevalence ratios by quartiles of sagittal abdominal diameter (SAD), waist circumference (WC) or body mass index
(BMI). Panel B: Prevalence ratios when SAD is considered simultaneously with WC (left side) or with BMI (right side). In age-adjusted models, the relative
prevalence of dysglycemia (HbA1c $5.7% [$39 mmol/mol]) is displayed in association with the second (circle), third (triangle), and fourth (square)
quartiles (with reference to first quartile) of each indicator. Error bars indicate 95% confidence intervals. a p,0.001; b p,0.01; c p,0.05.
doi:10.1371/journal.pone.0108707.g002
SAD Distribution in Adults, Correlation with Dysglycemia
PLOS ONE | www.plosone.org 4 October 2014 | Volume 9 | Issue 10 | e108707
indicator and compared the areas under these curves (AUCs) as
indices of fit for the various models. These sex-specific logistic
regression models included age and an adiposity indicator
modeled as continuous variables using natural splines with three
knots to allow for non-linearity. They also included a term for sex
when the sample included both men and women. Each model’s
goodness of fit was estimated as R2 (Nagelkerke method). We
assessed the difference in the AUCs between models using
jackknife resampling [24] with the ‘withReplicates’ function in R
[22] to estimate the standard error of the difference between
models.
Results
SAD means and selected percentile values for US adults are
presented in Table 1. These estimates for calendar years 2011–
2012 were derived from 4817 examined adults (irrespective of
metabolic status or other anthropometry; not pregnant) who
represented the US non-institutionalized, civilian, population of
approximately 224 million at age $20 years. The mean and
median values of SAD were greater for men than women. In both
sexes the means and medians of SAD increased with age at least
through 64 years.
Among adults without a diabetes diagnosis who were evaluated
for prevalent dysglycemia, the analytic subpopulation (subsample
n= 4037; excluding participants without information on HbA1c,
WC, or BMI) included dysglycemic persons with prediabetes or
undiagnosed diabetes. For our initial assessment of how dysgly-
cemia would be identified by the 3 adiposity indicators, the sex-
specific quartile cutoffs for SAD, WC and BMI are shown in
Table 2. The dimensions describing abdominal size (SAD and
WC) had cutoff values for men consistently larger than those for
women. However, for the indicator of generalized relative weight
(BMI), there was no consistent sex distinction for the quartile cutoff
values. The overall crude prevalence of dysglycemia in this
subpopulation was 26.4%, similar for men (25.9% [95%
confidence interval 23.5–28.3]) and women (26.8% [23.8–29.9]).
The crude dysglycemia prevalence estimates across the ordinal
quartiles demonstrated an increasing trend (p,0.01) of each
adiposity indicator (Table 3). In age-adjusted logistic models, the
ordinal quartiles of each adiposity indicator were likewise
associated with an increasing prevalence of dysglycemia (Figure 2,
Table 2. Subpopulation quartile cutoffs of adiposity indicators in US adults ages$20 years without diagnosed diabetes, estimated
from NHANES 2011–2012.
Quartile cutoffs (95% confidence interval)
Indicator Sex Subsample n 25th percentile 50th percentile 75th percentile
SAD, cm Total 4,037 19.0 (18.6–19.4) 21.6 (21.3–22.0) 24.8 (24.2–25.2)
Men 2,035 19.9 (19.5–20.4) 22.4 (22.0–22.9) 25.4 (24.8–25.9)
Women 2,002 18.3 (17.9–18.7) 20.8 (20.3–21.3) 24.0 (23.5–24.6)
WC, cm Total 4,037 86.0 (84.6–87.9) 96.0 (95.1–97.3) 106.5 (105.4–107.8)
Men 2,035 89.6 (87.5–91.7) 99.0 (97.5–100.6) 108.8 (107.7–110.5)
Women 2,002 82.9 (81.6–84.6) 93.4 (91.8–94.9) 104.1 (102.2–105.6)
BMI, kg/m2 Total 4,037 23.8 (23.5–24.4) 27.2 (26.8–27.7) 31.3 (30.8–31.9)
Men 2,035 24.3 (23.8–24.8) 27.5 (27.0–27.9) 31.0 (30.5–31.7)
Women 2,002 23.4 (23.0–23.9) 26.9 (26.3–27.5) 31.8 (31.0–32.5)
doi:10.1371/journal.pone.0108707.t002
Table 3. Crude prevalence (%) of dysglycemia by quartiles of adiposity indicators in US adults ages $20 years without diagnosed
diabetes, estimated from NHANES 2011–2012.
Crude prevalence (95% confidence interval) of dysglycemia, percentage
Indicator Sex 1st quartile 2nd quartile 3rd quartile 4th quartile
SAD Total 14.4 (10.8–18.9) 19.9 (16.3–24.0) 28.9 (25.6–32.5) 42.0 (37.4–46.7) I
Men 13.8 (10.1–18.7) 21.5 (16.4–27.7) 26.5 (21.2–32.5) 41.4 (36.1–46.9) I
Women 14.9 (10.4–20.7) 18.3 (14.1–23.3) 31.3 (25.8–37.3) 42.5 (35.4–50.0) I
WC Total 14.1 (10.7–18.4) 23.9 (21.1–27.0) 28.1 (23.9–32.7) 39.1 (34.6–43.7) I
Men 14.4 (10.5–19.4) 22.7 (19.4–26.5) 26.4 (21.5–32.0) 39.6 (33.9–45.7) I
Women 13.8 (10.0–18.8) 25.0 (19.4–31.6) 29.7 (24.0–36.1) 38.5 (33.0–44.3) 1
BMI Total 18.3 (14.4–22.9) 21.7 (17.3–26.7) 28.4 (24.6–32.6) 36.7 (32.0–41.7) I
Men 19.6 (14.6–25.7) 21.6 (17.1–26.7) 26.9 (22.1–32.2) 35.1 (29.0–41.7) I
Women 17.0 (12.0–23.5) 21.7 (16.1–28.7) 29.9 (24.7–35.8) 38.3 (32.0–45.1) I
Ip,0.001 for quartile trend.
1p,0.01 for quartile trend.
doi:10.1371/journal.pone.0108707.t003
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panel A). The explained variations in dysglycemia (multiple R2) for
these quartile-based models were 0.133 for SAD, 0.123 for WC,
and 0.125 for BMI. When SAD quartiles were simultaneously
considered with quartiles of WC in the model, SAD quartile 3 (PR
1.55; p,0.05) and quartile 4 (PR 2.39; p,0.001) remained
significantly different from SAD quartile 1 (Figure 2, panel B).
When quartiles of SAD were simultaneously considered with
quartiles of BMI in the same model, dysglycemia prevalence of
SAD quartile 3 (PR 1.45; p,0.05 vs quartile 1) and quartile 4 (PR
2.03; p,0.001 vs quartile 1) likewise remained significantly
elevated. However, for both of these models that tested
simultaneous indicators, the competing quartiles 3 and 4 of BMI
or WC were not significantly associated with dysglycemia.
When our age-adjusted models with competing quartiles (‘‘SAD
vs WC’’ or ‘‘SAD vs BMI’’) were restricted to either sex, SAD
quartiles 3 and 4 again provided elevated point estimates although
their confidence intervals did not always exclude one. For men
(subsample n= 2035), when competing with WC quartiles, the
SAD quartile 3 had PR 1.57 [0.89–2.76] and SAD quartile 4 had
PR 2.31 [1.36–3.92]; when SAD competed with BMI quartiles,
the men’s SAD quartile 3 had PR 1.57 [0.92–2.68] and SAD
quartile 4 had PR 2.28 [1.49–3.49]. For women (subsample
n= 2002), when competing with WC quartiles, the women’s SAD
quartile 3 had PR 1.60 [1.00–2.56] and SAD quartile 4 had PR
2.52 [1.56–4.06]; when SAD competed with BMI quartiles, the
SAD quartile 3 had PR 1.35 [0.84–2.16] and SAD quartile 4 had
PR 1.83 [1.15–2.92]. In these sex-specific models all the quartiles
of BMI or WC had weaker, non-significant associations with
dysglycemia (PRs ,1.21).
In the assessment of how well the continuous adiposity
indicators identified dysglycemia (our second approach), the
competing models adjusted for age and sex tended to confirm
that continuous SAD explained a greater proportion of dysglyce-
mia than continuous WC or BMI. Multiple R2 values for these
continuous models were 0.201 for SAD, 0.195 for WC, and 0.198
for BMI. The differences between these AUCs were non-
significant for the models in which both sexes were analyzed
together (Table 4), but sex interactions were found for all three
adiposity indicators. In sex-stratified analyses the men’s AUC for
SAD was greater (p,0.001) than the AUC for WC (but not
greater than the AUC for BMI); the women’s SAD area was
greater (p,0.001) than the AUC for either WC or BMI. In sex-
specific, age-adjusted curves we found for each of the adiposity
indicators that the relationship with dysglycemia was curvilinear
for men (J-shaped) but nearly linear for women (Figure 3).
Discussion
Adult SAD measurements obtained in NHANES 2011–2012
demonstrate the feasibility and utility of assessing abdominal
adiposity with a portable, sliding-beam caliper. Identical or very
similar anthropometric protocols have been used previously in
studies of diabetes, incident coronary heart disease and several
cardiometabolic risk factors among selected adults [11–14,16,25–
29] and in a Finnish national survey of persons $30 years [30].
The choice of the iliac crests (approximating lumbar interspace
L4–L5) as the most effective measurement landmark has been
recommended by reports that also evaluated alternative sites such
as the L3–L4 interspace, the umbilical level, or the highest point
on the abdomen [31–33].
The historical rationale for measuring SAD has been the
presumption that variation in this simple dimension would reflect
increases in the amount primarily of visceral AT. An early
proponent of the SAD pointed out that visceral AT would tend to
‘pump up’ the abdomen in the sagittal direction of supine subjects
[34], and later investigators confirmed that the surrounding
subcutaneous AT would tend to flow out at the flanks [35]. Recent
advances in AT imaging, however, have demonstrated that
subcutaneous AT contains distinct deep and superficial sub-
compartments, each with its own histologic and physiologic
characteristics. Deep abdominal subcutaneous AT may be located
primarily near the anatomic midline (as inferred from cross-
sectional abdominal images). This deep subcutaneous sub-com-
partment is associated, notably among men, with increased levels
of circulating HbA1c [36] and other cardiometabolic risk variables
[37]. Superficial abdominal subcutaneous AT is relatively more
Figure 3. Probability of prevalent dysglycemia estimated by continuous sagittal abdominal diameter, waist circumference or body
mass index. In these age-adjusted plots prepared by restricted cubic splines, the horizontal lines represent the interquartile range (p25 to p75) in the sex-
specific population distributions of each adiposity indicator.
doi:10.1371/journal.pone.0108707.g003
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prominent at the sides of the abdomen, and its physiologic
correlates are relatively benign. If the SAD incorporates primarily
the deep (midline) subcutaneous AT but less of the superficial
(lateral) AT, this might explain why prior research reported the
SAD, when compared to the area of visceral AT alone, was more
strongly associated with the metabolic syndrome and other
cardiometabolic risk variables [14,38,39].
The distinction between deep and superficial subcutaneous AT
may help to explain also why men, but not women, have a J-
shaped relation of adiposity to dysglycemia prevalence (Figure 3).
A deficit of superficial subcutaneous AT may be considered a
marker of metabolic dysfunction since adipocytes in this sub-
compartment are capable of safely storing energy during positive
caloric balance. Compared to women, men have lesser amounts of
superficial subcutaneous AT in the abdominal region [36,37].
Some men with low levels of generalized adiposity may have so
little superficial subcutaneous AT that any net excess of energy
intake will result in an overflow to less benign AT depots or to
ectopic sites such as the liver, skeletal muscle or pancreas. Others
have previously commented on metabolic dysfunctions that occur
when subcutaneous AT, irrespective of its sub-compartments, fails
to expand sufficiently in response to metabolic overload [40,41].
Given that the anthropometric methods of NHANES cannot
directly distinguish between the deep and superficial components
of subcutaneous AT, this speculative explanation of the J-shaped
relationship to dysglycemia cannot be tested in our dataset.
Type 2 diabetes has been related to adiposity phenotypes that
have an increased volume of visceral AT or elevations of hepatic
fat content [6,7,42]. An enlarged visceral adipose depot and
hepatic steatosis both represent forms of ectopic fat deposition.
Since the SAD is associated with visceral AT volume [34] it is
reasonable to expect that this easily measured external dimension
would be associated also with dysglycemia and with an increased
risk of diabetes. Direct assessments of hepatic fat content could
likewise provide correlations with dysglycemia and cardiometa-
bolic risk, but such assessments depend on liver biopsy or
technologies (e.g., multi-slice magnetic resonance or tomographic
imaging, magnetic resonance spectroscopy) that carry substantial
costs in time, money, and possibly radiation.
Our finding that SAD was associated with dysglycemia in the
general US adult population, independently of age and of WC or
BMI, confirms smaller studies of SAD restricted to obese adults
[13,28]. Hyperinsulinemia, a marker of insulin resistance, has
likewise been associated with SAD among young adults [12] and
among older men without diabetes [13]. A prospective comparison
from Finland of four adiposity indicators measured at ages $30
years has reported recently that the co-occurrence of high BMI
and high SAD, but not high WC or high waist-to-hip ratio, was
associated with the highest incidence of type 2 diabetes [30].
The absence of prospective, follow-up information is a major
limitation of our study. Current survey data from NHANES are
necessarily cross-sectional, although some earlier waves of
NHANES examinations have been followed by re-contact [43]
or mortality reviews [44]. Measurements of SAD within NHANES
did not begin, however, until 2011. The Finnish national survey
mentioned above was conducted in 2000–2001, and it employed
an SAD protocol nearly identical to that used by NHANES.
Smaller studies based on selected populations have reported
prospectively on mortality [45–47] and incident dementia [48] in
association with the SAD, but their anthropometric protocols
differed substantially from that of SAD in NHANES. With regard
to our participants who reported not having diabetes, another
possible limitation of our study is the dependence on an assay of
HbA1c to define the metabolic outcome of interest. However, the
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common limitations of HbA1c interpretation [49] are likely to be
minimized in our analyses since all HbA1c assays for NHANES
were performed by a single, highly standardized laboratory.
Consistent with physiologic and anatomic principles, the SAD
stands as a credible alternative to the conventional WC or BMI for
the clinical assessment of adiposity. As validated in this nationally
representative sample, SAD could inexpensively augment the
understanding of abdominal AT and its associated health risks.
The public-use NHANES data will provide opportunities to test
cross-sectional associations between SAD and many biomarkers or
clinical conditions. Future studies employing a prospective design
could expand on these findings and explore the associations of this
adiposity indicator with medical outcomes and mortality.
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